US21874A1060
US21874A1060
Core Scientific, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 4.95B EUR | 8.18B EUR | 4.74B EUR | 4.58B EUR |
Enterprise Value | 7.57B EUR | 10.71B EUR | 5.79B EUR | 5.43B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 94.68x | -- | -- | -- |
Price to Sales | 11.25x | 18.57x | 13.37x | 19.1x |
Price to Book | -- | -- | -- | -- |
EV/Revenue | 17.2x | 24.32x | 16.33x | 22.66x |
EV/EBITDA | -96.79x | 14.23x | 10.52x | 9.67x |
Price to FCF (P/FCF) | 10.65x | -- | -- | -- |
EV/FCF | 16.29x | -- | -- | -- |
FCF Yield | 9.39% | -11.71% | -9.73% | -7.03% |